SCHEMBL12692597

SCHEMBL12692597

CCOC(=O)NCCCCC(NC(=O)CC)C(=O)NCCNC(=O)CCN1C(=O)CC(NC)C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 1/20 0.36
▸ HDAC4 P56524 2/20 0.35
▸ EP300 Q09472 1/20 0.35
▸ MEF2D Q14814 1/20 0.35
▸ SIRT2 Q8IXJ6 4/20 0.34
▸ GLP1R P43220 8/20 0.33
▸ SIRT1 Q96EB6 3/20 0.33
▸ FOLH1 Q04609 1/20 0.33
▸ SIRT3 Q9NTG7 1/20 0.33
▸ KLK7 P49862 1/20 0.33
▸ KLK5 Q9Y337 1/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC7 Q8WUI4 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC10 Q969S8 1/20 0.33
▸ HDAC11 Q96DB2 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ HDAC9 Q9UKV0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL277682 0.95 SIRT2 (0.39) ACEHDAC4EP300MEF2DSIRT2
SCHEMBL13311607 0.88 SIRT2 (0.39) ACEHDAC4EP300MEF2DSIRT2
SCHEMBL12692605 0.88 FOLH1 (0.38) ACEHDAC4EP300MEF2DSIRT2
SCHEMBL14864098 0.87 SIRT2 (0.35) ACEHDAC4SIRT2GLP1RSIRT1
SCHEMBL9910894 0.84 SIRT2 (0.40) ACEHDAC4EP300MEF2DSIRT2
SCHEMBL14978142 0.84 SIRT2 (0.36) ACEHDAC4EP300MEF2DSIRT2
SCHEMBL12419082 0.84 SIRT2 (0.36) ACEHDAC4EP300MEF2DSIRT2
SCHEMBL12037876 0.84 ACE (0.35) ACEHDAC4EP300MEF2DSIRT2
SCHEMBL277487 0.82 SIRT2 (0.40) HDAC4EP300MEF2DSIRT2SIRT1
SCHEMBL12692598 0.82 HDAC4 (0.41) HDAC4EP300MEF2DSIRT2GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120245289-A1 POLYMER-FACTOR VIII MOIETY CONJUGATES NEKTAR THERAPEUTICS (US) 2012-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120245289-A1 POLYMER-FACTOR VIII MOIETY CONJUGATES F8, F9, F13B ACE 2726/4885HDAC4 3625/4885EP300 3089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback